Aji Bio-Pharma Business Announcements April 19, 2023 Ajinomoto Bio-Pharma Services Receives FDA Approval for High Potency Fill Line Read more March 14, 2023 Ajinomoto Bio-Pharma Services Awarded Three ‘CDMO Leadership Awards’ Read more February 22, 2023 Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase Read more January 10, 2023 Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer Read more September 26, 2022 Notice of Qualified Invoice Issuer Registration Number GeneDesign, Inc. – Osaka SiteRead more March 3, 2022 Ajinomoto Bio-Pharma Services Awarded Two ‘CMO Leadership Awards’ Read more January 25, 2022 Tony O’Neill Joins Ajinomoto Bio-Pharma Services’ Leadership Team as Vice President of Compliance Read more January 11, 2022 Notice on email address (for business use) changing GeneDesign, Inc. – Osaka SiteRead more November 22, 2021 Notice on email address changing GeneDesign, Inc. – Osaka SiteRead more November 10, 2021 [Reminder] Notice on email address domain changing GeneDesign, Inc. – Osaka SiteRead more May 25, 2021 Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity with New Multi-Purpose Fill Suite Read more March 30, 2021 Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement with AstraZeneca to Include Drug Product Manufacturing Read more Loading…Load More
